Skip to main content
FinSpry Logo
FinSpry
CLDX logo
CLDX
(NASDAQ)
Celldex Therapeutics, Inc.
$39.68-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Celldex Therapeutics (CLDX) Stock Price & Financial Analysis

Celldex Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$38.90 - $39.81
52-Week High$45.14
52-Week Low$22.10
Open$38.96
Volume414.53K
Average Volume (3M)808.63K
Market Cap2.64B
Shares Outstanding66.57M
Price to Sales (P/S)3221.14
Price to Book (P/B)5.79
EV/EBITDA-8.86
Revenue (TTM)820.00K
Net Income (TTM)-283.69M
Free Cash Flow (TTM)-225.96M
EPS (TTM)$-4.27
Profit Margin-34596.22%
Operating Margin-37694.63%
Return on Equity (ROE)-62.18%
Debt to Equity0.00
50-Day MA$39.01
200-Day MA$31.56
52-Week Change73.50%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Celldex Therapeutics

What is the current stock price for CLDX?

As of the latest trading session, CLDX stock trades at $39.68. The 52-week range is $22.10–$45.14, with a day range of $38.90–$39.81.

What is the P/E ratio for CLDX?

The P/E ratio (Price-to-Earnings) for CLDX is shown in the Key Statistics section. This valuation metric helps compare Celldex Therapeutics, Inc. to industry peers.

Does CLDX pay dividends?

Celldex Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CLDX?

Based on 8 analysts, the consensus for CLDX is Buy.

What is the market cap of CLDX?

Celldex Therapeutics's market capitalization is $2.64B, classifying it as a mid-cap company. Celldex Therapeutics operates in the Healthcare sector within the Biotechnology industry.